home / stock / mira / mira quote
Last: | $1.28 |
---|---|
Change Percent: | 0.0% |
Open: | $1.22 |
Close: | $1.28 |
High: | $1.29 |
Low: | $1.1475 |
Volume: | 204,914 |
Last Trade Date Time: | 03/21/2025 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.28 | $1.22 | $1.28 | $1.29 | $1.1475 | 204,914 | 03-21-2025 |
$1.22 | $1.22 | $1.22 | $1.26 | $1.1648 | 133,522 | 03-20-2025 |
$1.2 | $1.14 | $1.2 | $1.31 | $1.12 | 383,864 | 03-19-2025 |
$1.17 | $1.09 | $1.17 | $1.2 | $1.07 | 417,684 | 03-18-2025 |
$1.08 | $1.13 | $1.08 | $1.2 | $1.05 | 336,202 | 03-17-2025 |
$1.18 | $1.255 | $1.18 | $1.255 | $1.11 | 804,573 | 03-14-2025 |
$1.25 | $1 | $1.25 | $1.328 | $0.94 | 2,575,780 | 03-13-2025 |
$1 | $0.99 | $1 | $1 | $0.9162 | 152,583 | 03-12-2025 |
$0.968 | $0.9843 | $0.968 | $0.996 | $0.9039 | 102,665 | 03-11-2025 |
$0.97 | $0.9909 | $0.97 | $1.01 | $0.95 | 86,506 | 03-10-2025 |
$1.01 | $1.02 | $1.01 | $1.0603 | $0.9803 | 174,837 | 03-07-2025 |
$1.01 | $1.02 | $1.01 | $1.08 | $0.9862 | 161,756 | 03-06-2025 |
$1.01 | $0.9139 | $1.01 | $1.03 | $0.8859 | 119,843 | 03-05-2025 |
$0.93 | $0.94 | $0.93 | $0.9587 | $0.8 | 545,370 | 03-04-2025 |
$0.9099 | $0.99 | $0.9099 | $1 | $0.9 | 201,162 | 03-03-2025 |
$1 | $1.02 | $1 | $1.02 | $0.930763 | 170,478 | 02-28-2025 |
$1.02 | $1.04 | $1.02 | $1.08 | $0.99 | 275,547 | 02-27-2025 |
$1.03 | $1.02 | $1.03 | $1.05 | $1 | 56,586 | 02-26-2025 |
$1.02 | $1.01 | $1.02 | $1.06 | $0.97 | 226,932 | 02-25-2025 |
$1.02 | $1.11 | $1.02 | $1.11 | $1.01 | 341,124 | 02-24-2025 |
News, Short Squeeze, Breakout and More Instantly...
MIRA Pharmaceuticals Inc. Company Name:
MIRA Stock Symbol:
NASDAQ Market:
0.0% G/L:
$1.28 Last:
204,914 Volume:
$1.22 Open:
$1.28 Close:
MIRA Pharmaceuticals Inc. Website:
MIAMI, FLORIDA / ACCESSWIRE / December 19, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced that it has submitted an Investigational New Drug (IND) applicat...
Strong Safety Profile Validated Across Studies, Setting the Stage for Clinical Trials in Neuropathic Pain MIAMI, FL / ACCESSWIRE / December 10, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company, proudly announces the successful completion of its cur...
MIRA Pharmaceuticals Inc. (MIRA) is expected to report $-0.18 for Q3 2024